Skip to main content

Webinar on demand

Realizing the full potential of clinicogenomics

Length: 50 minutes


Paving the way for new health discoveries

Hailed as the next frontier in drug discovery and development, genomics has, in many ways, fallen short. One reason is the lack of existing datasets combining high-quality genomic sequencing information and rich, longitudinal phenotypic information.

During this Endpoints News webinar, industry experts discuss the progress made in clinicogenomics, the development of these datasets and their application in health care, drug discovery and development.

Learn more about Optum Life Sciences here


Dr. Ashley Brenton, VP, Real-World Evidence and Genomics, Life Sciences, Optum


Dr. Michael Hultner, VP, Head of Genomics Strategy, Optum Arsalan Arif, Founder and Publisher, Endpoints News (moderator)

Related resources

Clinicogenomics: The next big leap in real-world data

Optum clinical genomics is positioned to shape a new generation of evidence that accelerates understanding of disease.

Clinicogenomics: new, linked data is advancing research

Rich, longitudinal clinicogenomics data can fuel all stages of drug development.

Clinicogenomics Enable Precision Drug Development | Optum